Benlysta Will Garner Sales of More Than $500 Million in 2018 in the Systemic Lupus Erythematosus Drug Market

Monday, February 1, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

Following Its Expected Approval, Benlysta Will Be the First Agent to Launch for the Disease in More Than 40 Years, According to New Findings from Decision Resources

Decision Resources

Decision Resources, Inc.

Gisselle Morales

Christopher Comfort

781-296-2691

781-296-2597

[email protected]

[email protected]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook